Hemispherx Biopharma Inc (NYSE American:HEB)

0.355
Delayed Data
As of Apr 20
 -0.025 / -6.58%
Today’s Change
0.30
Today|||52-Week Range
0.84
+2.60%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-17.5M-15.2M-7.5M-8.3M
 
 
 
 
 
Depreciation1.1M975.0K1.2M1.0M
 
 
 
 
 
Total Other Cash Flow457.0K774.0K-1.1M-1.8M
 
 
 
 
 
Funds From Operations-15.9M-13.5M-7.4M-9.1M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.9M2.6M-29.0K-1.1M
 
 
 
 
 
Net Cash Flow - Operating Activities-13.9M-16.1M-7.4M-7.9M
 
 
 
 
 
 
InvestingDecrease In Investments3.2M6.8M3.4M2.8M
 
 
 
 
 
Capital Expenditures-504.0K-240.0K-160.0K-20.0K
 
 
 
 
 
Other Investing - Sources2.0K0.00----
 
 
Net Cash Flow Investing2.5M6.4M2.9M2.7M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00----0.00--
Long Term Borrowings0.00--14.0K1.8M
 
 
 
Long Term Debt Reduction-34.0K-21.0K-1.0K0.00
 
 
 
 
Net Proceeds Stock Sale12.8M9.7M4.7M2.4M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing12.8M9.7M4.8M4.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash1.4M-41.0K293.0K-996.0K